MR. BRUCE EDWIN VANNATTA, MD

LOS ALAMITOS, CA

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 3 publications 1993 – 2017 NPI: 1629074877
BiomarkersDouble-Blind MethodAdministration, OralCatheterization, PeripheralPainInfant, PrematureHeart RateElectrocardiographyPain MeasurementAngina, UnstableChest PainFacial ExpressionOximetrySucroseSweetening Agents

Practice Location

3801 KATELLA AVE
LOS ALAMITOS, CA 90720-3338

Phone: (562) 598-3200

What does BRUCE VANNATTA research?

Dr. Vannatta studies methods of pain relief for newborns and ways to identify heart attacks in patients experiencing chest pain. He tested whether a sugar solution could ease pain during a common medical procedure for infants, as well as researched blood markers that can help doctors quickly determine if someone is having a heart attack. By exploring these two areas, he aims to improve patient care in both newborns and adults experiencing serious health issues.

Key findings

  • In the study on sucrose for pain relief, pain scores increased significantly during catheter insertion, indicating sucrose did not effectively reduce pain in newborns.
  • In his research on chest pain, 78% of patients having a heart attack had at least one elevated biochemical marker, compared to only 40% with a traditional marker (CK-MB).
  • Using all four blood markers in chest pain patients could facilitate quicker diagnoses, potentially saving healthcare systems $264,000 by allowing non-admitted patients to go home safely.

Frequently asked questions

Does Dr. Vannatta study pain management for newborns?
Yes, Dr. Vannatta researches ways to reduce pain in newborns, specifically during procedures like catheter insertions.
What treatments has Dr. Vannatta researched for chest pain?
He investigated the use of four biochemical markers to help diagnose heart attacks more effectively.
Is Dr. Vannatta's work relevant to emergency room patients?
Yes, his findings on chest pain diagnostics are directly applicable to emergency room patients who may be having heart attacks.
What implications does Dr. Vannatta's research have for healthcare costs?
His work suggests that using advanced blood markers can save hospitals significant money by reducing unnecessary admissions.

Publications in plain English

Randomized Clinical Trial of 24% Oral Sucrose to Decrease Pain Associated With Peripheral Intravenous Catheter Insertion in Preterm and Term Newborns.

2017

Advances in neonatal care : official journal of the National Association of Neonatal Nurses

Cook LM, Nichols-Dada J, Damani S, Lawrence V, Layson S +7 more

Plain English
This study examined whether giving a 24% sucrose (sugar) solution to newborns before inserting a peripheral intravenous catheter would reduce their pain. Researchers found that pain scores increased significantly during the catheter insertion, but there was no difference in pain levels between those who received sucrose and those who received a placebo, indicating that the sucrose did not reduce pain. This matters because it shows that a common method used to ease pain in other situations is not effective in this specific procedure. Who this helps: This helps doctors and caregivers understand the limits of using sucrose for pain relief in newborns during catheter insertions.

PubMed

The utility of four biochemical markers in the triage of chest pain patients.

2000

Cardiology

Ellestad MH, Startt-Selvester R, Stanton E, VanNatta B, Ahmad J +2 more

Plain English
This study looked at four blood markers in 1,338 patients with chest pain to see how well they could help identify those having a heart attack. They found that 78% of patients having a heart attack had at least one elevated marker right away, while only 40% had an elevated traditional marker (CK-MB). By using all four markers, doctors could make quicker diagnoses of heart disease and potentially save $264,000 by safely discharging patients who didn't need to be admitted. Who this helps: This helps patients with chest pain and doctors in emergency departments.

PubMed

Torsade de pointes induced by astemizole in a patient with prolongation of the QT interval.

1993

American heart journal

Sakemi H, VanNatta B

PubMed

Frequent Co-Authors

Linda M Cook Jacinth Nichols-Dada Samina Damani Vickie Lawrence Sandra Layson Diane Mitchell Shaqunna Muhammad Lourdes Samaniego-Yamin Jacquelyn Walters Talley Melinda Higgins

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.